This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast February 27, 2025. How reliable is the current research into the cause of…
Dr. Louis Sullivan walked the halls of Congress and testified before committees when he was…
Originally broadcast February 13, 2025 $4.95 — that’s the record high price of a dozen…
Originally broadcast February 6, 2025 Artificial intelligence is revolutionizing health care—but how do we ensure…
Originally broadcast January 30, 2025. Noted healthcare leader Dr. Sachin Jain has been publicly releasing…
Originally broadcast January 23, 2025 President Trump’s first days in office have resulted in a…